Détail de l'auteur
Auteur Alberto Esquenazi |
Documents disponibles écrits par cet auteur



International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi / Marjorie Salga ; Laure Gatin ; Thierry Deltombe ; Thierry Gustin ; Stefano Carda ; Philippe Marque ; Paul Winston ; Rajiv Reebye ; Theodore Wein ; Alberto Esquenazi ; Mary-Ann Keenan ; Franco Molteni ; Paolo Zerbinati ; Alessandro Picelli ; Flavia Coroian ; Bertrand Coulet ; Nadine Sturbois-Nachef ; Christian Fontaine ; Alain Yelnik ; Bernard Parratte ; Prakash Henry ; Srikant Venkatakrishnan ; Philippe Rigoard ; Romain David ; Philippe Denormandie ; Alexis Schnitzler ; Étienne Allart ; François Genet in Archives of Physical Medicine and Rehabilitation, Vol. 104, n° 3 (2023)
![]()
[article]
Titre : International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi Type de document : Article Auteurs : Marjorie Salga ; Laure Gatin ; Thierry Deltombe ; Thierry Gustin ; Stefano Carda ; Philippe Marque ; Paul Winston ; Rajiv Reebye ; Theodore Wein ; Alberto Esquenazi ; Mary-Ann Keenan ; Franco Molteni ; Paolo Zerbinati ; Alessandro Picelli ; Flavia Coroian ; Bertrand Coulet ; Nadine Sturbois-Nachef ; Christian Fontaine ; Alain Yelnik ; Bernard Parratte ; Prakash Henry ; Srikant Venkatakrishnan ; Philippe Rigoard ; Romain David ; Philippe Denormandie ; Alexis Schnitzler ; Étienne Allart ; François Genet Année de publication : 2023 Article en page(s) : p. 372-379 Langues : Anglais (eng) Descripteurs : HE Vinci
Association sportive ; Football ; Hypertonie musculaire ; Méthode Delphi ; RéadaptationRésumé : Objective To establish international recommendations for the management of spastic equinovarus foot deformity. Design Delphi method. Setting International study. Participants A total of 24 international experts (N=24) in neuro-orthopedic deformities, from different specialties (Physical and Rehabilitation Medicine physicians, neurologists, geriatricians, orthopedic surgeons, neurosurgeons, plastic surgeons). Interventions Experts answered 3 rounds of questions related to important aspects of diagnosis, assessment, and treatment of spastic equinovarus foot deformity. Main Outcome Measures A consensus was established when at least 80% of experts agreed on a statement Results A total of 52 items reached consensus. Experts recommend assessing effect of the deformity on functional activities before treatment. Before treatment, it is crucial to differentiate spastic muscle overactivity from soft tissue contractures, identify which muscles are involved in the deformity, and evaluate the activity of antagonist muscles. Motor nerve blocks, 2-dimensional video analysis, and radiologic examinations are often required to complement a clinical examination. The treatment of equinovarus foot depends on the correctability of the deformity and the patient's ability to stand or walk. The preoperative assessment should include an interdisciplinary consultation that must finalize a formal agreement between physicians and the patient, which will define personalized attainable goals before surgery. Conclusion The establishment of guidelines on managing equinovarus foot will help physicians and surgeons, specialists, and nonspecialists to diagnoses and assess the deformity and direct patients to a network of experts to optimize patient functional recovery and improve their autonomy. Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/a [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=303845
in Archives of Physical Medicine and Rehabilitation > Vol. 104, n° 3 (2023) . - p. 372-379[article]Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study / Alberto Esquenazi in Archives of Physical Medicine and Rehabilitation, Vol. 102, n° 11 (2021)
![]()
[article]
Titre : Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study Type de document : Article Auteurs : Alberto Esquenazi ; Gerard E. Francisco ; Wuwei Feng ; Alessio Baricich ; Philippe Gallien ; Kristina Fanning ; Aleksej Zuzek ; Daniel S. Bandari ; George F. Wittenberg Année de publication : 2021 Article en page(s) : p. 2172-2184.e6 Note générale : https://doi.org/10.1016/j.apmr.2021.06.008 Langues : Anglais (eng) Descripteurs : HE Vinci
Accident vasculaire cérébral (AVC) ; Adhésion et observance thérapeutiques ; Réadaptation ; Toxines botuliniques ou botuliquesRésumé : Objective
To identify baseline characteristics and treatment-related variables that affect adherence to onabotulinumtoxinA treatment from the Adult Spasticity International Registry (ASPIRE) study.
Design
Prospective, observational registry (NCT01930786).
Setting
International clinical sites.
Participants
Adults with spasticity (N=730).
Interventions
OnabotulinumtoxinA at clinician's discretion.
Main Outcome Measures
Clinically meaningful thresholds used for treatment adherent (≥3 treatment sessions during 2-year study) and nonadherent (≤2 sessions). Data analyzed using logistic regression and presented as odds ratios (ORs) with 95% confidence intervals (CIs). Treatment-related variables assessed at sessions 1 and 2 only.
Results
Of the total population, 523 patients (71.6%) were treatment adherent with 5.3±1.6 sessions and 207 (28.4%) were nonadherent with 1.5±0.5 sessions. In the final model (n=626/730), 522 patients (83.4%) were treatment adherent and 104 (16.6%) were nonadherent. Baseline characteristics associated with adherence: treated in Europe (OR=1.84; CI, 1.06-3.21; P=.030) and use of orthotics (OR=1.88; CI, 1.15-3.08; P=.012). Baseline characteristics associated with nonadherence: history of diplopia (OR=0.28; CI, 0.09-0.89; P=.031) and use of assistive devices (OR=0.51; CI, 0.29-0.90; P=.021). Treatment-related variables associated with nonadherence: treatment interval ≥15 weeks (OR=0.43; CI, 0.26-0.72; P=.001) and clinician dissatisfaction with onabotulinumtoxinA to manage pain (OR=0.18; CI, 0.05-0.69; P=.012). Of the population with stroke (n=411), 288 patients (70.1%) were treatment adherent with 5.3±1.6 sessions and 123 (29.9%) were nonadherent with 1.5±0.5 session. In the final stroke model (n=346/411), 288 patients (83.2%) were treatment adherent and 58 (16.8%) were nonadherent. Baseline characteristics associated with adherence: treated in Europe (OR=2.99; CI, 1.39-6.44; P=.005) and use of orthotics (OR=3.18; CI, 1.57-6.45; P=.001). Treatment-related variables associated with nonadherence: treatment interval ≥15 weeks (OR=0.42; CI, 0.21-0.83; P=.013) and moderate/severe disability on upper limb Disability Assessment Scale pain subscale (OR=0.40; CI, 0.19-0.83; P=.015).
Conclusions
These ASPIRE analyses demonstrate real-world patient and clinical variables that affect adherence to onabotulinumtoxinA and provide insights to help optimize management strategies to improve patient care.Disponible en ligne : Oui En ligne : https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/a [...] Permalink : https://bib.vinci.be/opac_css/index.php?lvl=notice_display&id=285895
in Archives of Physical Medicine and Rehabilitation > Vol. 102, n° 11 (2021) . - p. 2172-2184.e6[article]